Text Correction A novel technology for home monitoring of lupus nephritis that tracks the pathogenic urine biomarker, ALCAM

Rongwei Lei¹Binh Vu¹Katerina Kourentzi¹Sanam Soomro¹Adheesha Danthanarayana¹Jakoah Brgoch¹Suma Nadimpalli¹Michelle Petri²Chandra Mohan^1*Richard Willson^1*

• ¹University of Houston, Houston, United States
• ²Johns Hopkins University, Baltimore, United States

In the published article, there was an error. The interests of some authors in a company developing a different LFA technology should also have been cited in the Conflict of Interest section, along with the disclosure of interest in the technology used in this work. This section previously stated: "Conflict of interest RW is a named inventor on IP covering the use of nanophosphors in lateral flow assays, and may receive income from its commercialization by Clip Health, Inc.The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be constructed as a potential conflict of interest."The corrected section appears below: "Conflict of interest RW is a named inventor on IP covering the use of nanophosphors in lateral flow assays, and may receive income from its commercialization by Clip Health, Inc. Also, Willson, Kourentzi, and Vu acknowledge their financial interest in Glow Nanotech which at the time was developing a different LFA technology.The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be constructed as a potential conflict of interest."The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.